drugset / Trial / NCT00748787

Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents

NCT00748787

Phase 2 Terminated 19 enrolled Rottapharm Spain
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The metabolic syndrome represents a constellation of risk factors associated to the abdominal obesity that includes insulin resistance, lipids alterations, high blood pressure etc. Several studies support the hypothesis that the intake of soluble fiber might have a positive effect in the improvement of such of these risk factors. So that, the aim of this study is to evaluate the efficacy of Ispaghula husk in the remission of metabolic syndrome in children between 10 to 16 years old.

Timeline

Start
2008-10
Primary completion
2009-11
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ispaghula husk Unknown 3.5 g Oral

Indications